JMP Securities reissued their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS – Free Report) in a research report report published on Wednesday,Benzinga reports. JMP Securities currently has a $150.00 price objective on the stock.
A number of other equities analysts have also recently commented on the stock. Macquarie reaffirmed an “outperform” rating and set a $133.00 price objective on shares of Addus HomeCare in a research report on Tuesday, June 10th. Wall Street Zen raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Sunday, June 29th. Seven investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $142.57.
Check Out Our Latest Research Report on Addus HomeCare
Addus HomeCare Price Performance
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business had revenue of $337.71 million during the quarter, compared to analysts’ expectations of $341.66 million. During the same period last year, the business earned $1.21 earnings per share. The firm’s revenue was up 20.3% on a year-over-year basis. On average, research analysts expect that Addus HomeCare will post 4.59 EPS for the current fiscal year.
Insider Buying and Selling
In other news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president owned 7,796 shares of the company’s stock, valued at approximately $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.60% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Addus HomeCare
A number of hedge funds and other institutional investors have recently modified their holdings of ADUS. Natixis lifted its holdings in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after buying an additional 132 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Addus HomeCare during the first quarter worth $41,000. Meeder Asset Management Inc. acquired a new stake in shares of Addus HomeCare during the fourth quarter worth $77,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Addus HomeCare during the fourth quarter worth $86,000. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in shares of Addus HomeCare by 368.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company’s stock worth $124,000 after buying an additional 987 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
- Five stocks we like better than Addus HomeCare
- What Are Treasury Bonds?
- Why Pure Storage Is a Core Investment for the AI Era
- 3 Small Caps With Big Return Potential
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.